MedPath

Morton Grove Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

FDA:30

Drug Approvals

Amoxicillin and Clavulanate Potassium

Approval Date
Nov 9, 2023
FDA

LIDOCAINE HYDROCHLORIDE

Approval Date
Mar 10, 2022
FDA

Oxycodone Hydrochloride

Approval Date
Nov 10, 2021
FDA

Prednisolone Sodium Phosphate

Approval Date
Sep 23, 2021
FDA

Valproic Acid

Approval Date
Jan 22, 2021
FDA

Bromfed DM

Approval Date
Jan 11, 2021
FDA

Promethazine Hydrochloride and Dextromethorphan Hydrobromide

Approval Date
Jan 11, 2021
FDA

Lindane

Approval Date
Dec 30, 2020
FDA

Levetiracetam

Approval Date
Oct 15, 2020
FDA

Megestrol Acetate

Approval Date
Jun 10, 2020
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.